Anne Daub is a Partner on the Therapeutics team at Deerfield, joining in 2024. She previously held analyst and vice president roles at several investment firms and holds a graduate degree in Finance.
At firms with a similar stage, sector and check size.




One email when Anne's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckAnne Daub is a Partner on the Therapeutics team at Deerfield, joining in 2024. She previously held analyst and vice president roles at several investment firms and holds a graduate degree in Finance.
Deerfield has not reported a check size. It invests at seed.
A warm intro from a founder Deerfield backed works best.
Analyst at Visium Asset Management; Senior Analyst at Soros Fund Management LLC; Senior Analyst at Citadel LLC; Vice President and Biotechnology Senior Analyst at T. Rowe Price; J.P. Morgan Securities Inc.; Integrated Finance Ltd.; Bear Stearns & Co..
Last updated 2026-10-15. Is this you? Ask for a correction.